Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8M Buy
142,723
+137,873
+2,843% +$28.6M 0.22% 72
2026
Q1
$1.09M Sell
4,850
-7,253
-60% -$1.81M 0.01% 890
2025
Q4
$2.92M Buy
12,103
+8,480
+234% +$2.17M 0.04% 541
2025
Q3
$992K Sell
3,623
-18,514
-84% -$5.06M 0.01% 1025
2025
Q2
$5.71M Buy
+22,137
New +$5.28M 0.06% 375
2025
Q1
Sell
-7,978
Closed -$1.82M 1959
2024
Q4
$1.82M Buy
7,978
+1,552
+24% +$374K 0.04% 544
2024
Q3
$1.57M Buy
6,426
+5,322
+482% +$1.19M 0.03% 607
2024
Q2
$211K Sell
1,104
-3,888
-78% -$789K ﹤0.01% 1544
2024
Q1
$989K Buy
4,992
+3,307
+196% +$606K 0.03% 808
2023
Q4
$290K Sell
1,685
-12,481
-88% -$1.92M 0.01% 1360
2023
Q3
$2.09M Sell
14,166
-15,251
-52% -$2.76M 0.08% 350
2023
Q2
$6.43M Sell
29,417
-3,883
-12% -$865K 0.24% 80
2023
Q1
$7.29M Buy
33,300
+31,520
+1,771% +$6.84M 0.3% 46
2022
Q4
$370K Buy
+1,780
New +$391K 0.02% 914
2022
Q3
Sell
-1,406
Closed -$295K 1904
2022
Q2
$295K Buy
+1,406
New +$299K 0.01% 1080
2020
Q4
Sell
-2,235
Closed -$383K 1142
2020
Q3
$383K Buy
+2,235
New +$413K 0.08% 415

Other funds holding RMD

Jump Financial's RMD Position: Q2 2026 in Review

Jump Financial increased its ResMed (RMD) stake by 2,843% in Q2 2026, buying an estimated $28.6M and bringing the position to 142,723 shares worth $27.8M. The position accounts for 0.22% of the portfolio, ranked #72.

Jump Financial first reported a position in RMD in Q3 2020 and has held it in 16 quarters since. 890 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jump Financial held 142,723 shares of ResMed worth $27.8M as of Q2 2026.
  • Jump Financial bought 137,873 ResMed shares in Q2 2026, an estimated $28.6M.
  • ResMed made up 0.22% of Jump Financial's portfolio in Q2 2026, its #72 holding.
  • Jump Financial first reported a position in ResMed in Q3 2020 and has held it in 16 quarters since.
  • 890 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.